Expert Practice in Hematology

Meeting Overview

On behalf of Aristoteles Giagounidis, MD, PhD, we are pleased to invite you to the Expert Practice^SM in Hematology meeting in Amsterdam, the Netherlands, on 6 March 2010.

During this case-based meeting, leaders in the field discuss with participants, in an interactive format, clinical issues encountered daily by practicing physicians.

Delegates will receive:

Round trip economy air or train transportation

Hotel accommodation will be offered on 5 March 2010.

Meeting venue
Renaissance Amsterdam Hotel Kattengat 1 1012 SZ Amsterdam the Netherlands

Faculty

Chairman
Aristoteles Giagounidis, MD, PhD St. Johannes Hosipital Duisburg, Germany
Faculty:
Julio Delgado, MD, PhD Hospital de la Santa Creu I Sant Pau Barcelona, Spain	Mathias Rummel, MD University of Giessen Giessen, Germany
Thierry Facon, MD Lille University Hospital Lille, France	Roberto Stasi, MD, PhD St Georges Healthcare NHS Trust London, United Kingdom
Norbert Gattermann, MD, PhD University of Düsseldorf Düsseldorf, Germany	Thorsten Zenz, MD University of Ulm Ulm, Germany
Henk Lokhorst, MD University Medical Center Utrecht Utrecht, the Netherlands

Agenda

9.00		Welcome, introduction and demographic questions Aristoteles Giagounidis, MD, PhD
9.20		Case #1—Chronic lymphocytic leukemia: New advances in research and treatment Thorsten Zenz, MD
9.55		Case #2—Low-risk myelodysplastic syndromes: Is there a new standard of care? Aristoteles Giagounidis, MD, PhD
10.30		Break
11.00		Case #3—Emerging options for a patient with follicular lymphoma Mathias Rummel, MD
11.35		Case #4—Initial treatment of an elderly patient with multiple myeloma Thierry Facon, MD
12.10		Case #5—Transfusion dependent myelodysplastic syndrome: Managing iron overload Norbert Gattermann, MD, PhD
12.45		Lunch
13.45		Case #6— Relapsed/refractory multiple myeloma: Advances in treatment Henk Lokhorst, MD
14.20		Case #7—Imatinib-resistant chronic myelogenous leukemia: Optimal use of TKIs Julio Delgado, MD, PhD
14.55		Case #8—Idiopathic thrombocytopenic purpura: New opportunities for management Roberto Stasi, MD, PhD
15.30		Concluding Remarks